VTAK Jumps 17%

Catheter Precision Inc. 08 after the bell on Tuesday, as investors cheered the firm’s partnership with sports and entertainment agency GSE Worldwide and a batch of newly allowed patents covering its heart failure and vascular closure technologies. S. Open.

Grillo climbed as high as third on the leaderboard before finishing tied for 23rd in one of golf’s most competitive major championships. Flyte’s Cirrus Vision Jets target short-haul regional routes, a natural fit for athletes juggling packed tournament schedules. S. patent for its LockeT product, a suture retention device used after catheterization procedures.

The additions push VTAK’s IP library past 50 patents. 48 million. 75. 92.

51%. 16 million, signaling strong investor interest. The small-cap stock of the South Carolina-based medical device and technology company is currently trading close to its annual low. 78%.

Benzinga’s Edge Stock Rankings indicate that VTAK is experiencing long-term consolidation along with medium and short-term upward movement. com Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published editors. Read Also: Megan Holdings (MGN) Stock Is Trending Overnight — Here's Why It Spiked 92% In After-Hours Session